Evoke Pharma (EVOK) Competitors $2.74 -0.05 (-1.61%) As of 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock EVOK vs. BCTX, CARM, COCP, SLGL, MEIP, IMNN, SYBX, LPTX, NRSN, and IXHLShould you be buying Evoke Pharma stock or one of its competitors? The main competitors of Evoke Pharma include BriaCell Therapeutics (BCTX), Carisma Therapeutics (CARM), Cocrystal Pharma (COCP), Sol-Gel Technologies (SLGL), MEI Pharma (MEIP), Imunon (IMNN), Synlogic (SYBX), Leap Therapeutics (LPTX), NeuroSense Therapeutics (NRSN), and Incannex Healthcare (IXHL). These companies are all part of the "pharmaceutical products" industry. Evoke Pharma vs. BriaCell Therapeutics Carisma Therapeutics Cocrystal Pharma Sol-Gel Technologies MEI Pharma Imunon Synlogic Leap Therapeutics NeuroSense Therapeutics Incannex Healthcare BriaCell Therapeutics (NASDAQ:BCTX) and Evoke Pharma (NASDAQ:EVOK) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, community ranking, valuation, earnings, dividends and media sentiment. Does the media prefer BCTX or EVOK? In the previous week, Evoke Pharma had 1 more articles in the media than BriaCell Therapeutics. MarketBeat recorded 3 mentions for Evoke Pharma and 2 mentions for BriaCell Therapeutics. BriaCell Therapeutics' average media sentiment score of 0.94 beat Evoke Pharma's score of 0.63 indicating that BriaCell Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BriaCell Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Evoke Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation and earnings, BCTX or EVOK? BriaCell Therapeutics has higher earnings, but lower revenue than Evoke Pharma. BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Evoke Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriaCell TherapeuticsN/AN/A-$4.79M-$5.03-0.79Evoke Pharma$10.25M0.40-$7.79M-$4.40-0.62 Which has more volatility and risk, BCTX or EVOK? BriaCell Therapeutics has a beta of 1.71, indicating that its stock price is 71% more volatile than the S&P 500. Comparatively, Evoke Pharma has a beta of 0.12, indicating that its stock price is 88% less volatile than the S&P 500. Do institutionals and insiders hold more shares of BCTX or EVOK? 15.4% of BriaCell Therapeutics shares are owned by institutional investors. 5.7% of BriaCell Therapeutics shares are owned by company insiders. Comparatively, 6.1% of Evoke Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community favor BCTX or EVOK? Evoke Pharma received 348 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. However, 100.00% of users gave BriaCell Therapeutics an outperform vote while only 58.35% of users gave Evoke Pharma an outperform vote. CompanyUnderperformOutperformBriaCell TherapeuticsOutperform Votes12100.00% Underperform VotesNo VotesEvoke PharmaOutperform Votes36058.35% Underperform Votes25741.65% Is BCTX or EVOK more profitable? BriaCell Therapeutics has a net margin of 0.00% compared to Evoke Pharma's net margin of -71.32%. BriaCell Therapeutics' return on equity of 0.00% beat Evoke Pharma's return on equity.Company Net Margins Return on Equity Return on Assets BriaCell TherapeuticsN/A N/A -191.19% Evoke Pharma -71.32%-308.49%-53.66% Do analysts prefer BCTX or EVOK? BriaCell Therapeutics currently has a consensus price target of $32.00, indicating a potential upside of 706.05%. Given BriaCell Therapeutics' stronger consensus rating and higher possible upside, equities analysts clearly believe BriaCell Therapeutics is more favorable than Evoke Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BriaCell Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Evoke Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryBriaCell Therapeutics beats Evoke Pharma on 10 of the 17 factors compared between the two stocks. Remove Ads Get Evoke Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EVOK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVOK vs. The Competition Export to ExcelMetricEvoke PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.10M$6.93B$5.63B$7.83BDividend YieldN/A2.73%4.57%4.00%P/E Ratio-0.257.1623.1218.67Price / Sales0.40221.41388.1791.15Price / CashN/A65.6738.1634.64Price / Book-0.306.386.884.23Net Income-$7.79M$142.12M$3.20B$247.15M7 Day Performance-2.66%-4.83%-2.86%-2.16%1 Month Performance-41.09%-7.22%1.72%-5.71%1 Year Performance-62.50%-8.75%9.77%-0.81% Evoke Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVOKEvoke Pharma0.7997 of 5 stars$2.75-1.6%N/A-61.6%$4.10M$10.25M-0.254Analyst ForecastShort Interest ↓BCTXBriaCell Therapeutics1.9291 of 5 stars$4.46-0.2%$32.00+617.5%-89.9%$16.54MN/A-0.338CARMCarisma Therapeutics3.2985 of 5 stars$0.39-4.8%$4.94+1,154.8%-84.0%$16.44M$20.27M-0.2520COCPCocrystal Pharma3.2369 of 5 stars$1.58+1.3%$7.00+343.0%-4.7%$16.08MN/A-0.8510Short Interest ↓Gap UpSLGLSol-Gel Technologies2.4421 of 5 stars$0.57+9.7%$5.00+776.6%-48.1%$15.89M$11.71M-1.6850Upcoming EarningsShort Interest ↑Gap UpMEIPMEI Pharma4.3337 of 5 stars$2.35+2.2%$7.00+197.9%-40.8%$15.66M$65.30M-0.41100Short Interest ↓IMNNImunon2.2712 of 5 stars$1.07+12.1%$20.50+1,824.9%-18.6%$15.57M$500,000.00-0.5630Analyst ForecastPositive NewsSYBXSynlogic1.8277 of 5 stars$1.29-0.7%N/A-28.1%$15.10M$8,000.00-0.3180Positive NewsLPTXLeap Therapeutics2.466 of 5 stars$0.39-2.7%$4.92+1,160.7%-86.9%$14.94MN/A-0.2040Earnings ReportUpcoming EarningsAnalyst ForecastShort Interest ↓News CoverageGap DownNRSNNeuroSense Therapeutics0.7485 of 5 stars$1.08+0.9%N/A-39.9%$14.76MN/A-1.6910Gap UpIXHLIncannex Healthcare0.901 of 5 stars$0.80-3.5%N/A-77.8%$14.29M$98,000.00-0.583Positive News Remove Ads Related Companies and Tools Related Companies BCTX Alternatives CARM Alternatives COCP Alternatives SLGL Alternatives MEIP Alternatives IMNN Alternatives SYBX Alternatives LPTX Alternatives NRSN Alternatives IXHL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EVOK) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evoke Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
